Current:Home > ContactThe FDA clears updated COVID-19 vaccines for kids under age 5 -WealthSpot
The FDA clears updated COVID-19 vaccines for kids under age 5
View
Date:2025-04-27 18:40:42
U.S. regulators on Thursday cleared doses of the updated COVID-19 vaccines for children younger than age 5.
The Food and Drug Administration's decision aims to better protect the littlest kids amid an uptick in COVID-19 cases around the country — at a time when children's hospitals already are packed with tots suffering from other respiratory illnesses including the flu.
"Vaccination is the best way we know to help prevent the serious outcomes of COVID-19, such as hospitalization and death," Dr. Peter Marks, FDA's vaccine chief, told The Associated Press.
Omicron-targeted booster shots made by Moderna and rival Pfizer already were open to everyone 5 and older.
The FDA now has authorized use of the tweaked shots starting at age 6 months — but just who is eligible depends on how many vaccinations they've already had, and which kind. Only about 5% of youngsters under age 5 have gotten the full primary series since vaccinations for the littlest kids began in June.
The FDA decided that:
--Children under age 6 who've already gotten two original doses of Moderna's COVID-19 vaccine can get a single booster of Moderna's updated formula if it's been at least two months since their last shot.
--Pfizer's vaccine requires three initial doses for tots under age 5 — and those who haven't finished that vaccination series will get the original formula for the first two shots and the omicron-targeted version for their third shot.
The Centers for Disease Control and Prevention is expected to sign off soon, the final step for shots to begin.
Marks said the bivalent vaccine is safe for tots and will help parents "keep the protection for those children as up to date as possible."
But children under 5 who already got all three Pfizer doses aren't yet eligible for an updated booster.
For now, "the good news is they are probably reasonably well-protected," Marks said.
The FDA expects data from Pfizer and its partner BioNTech sometime next month to determine whether those tots will need an omicron-targeted booster "and we will act on that as soon as we can," he said.
For parents who haven't yet gotten their children vaccinated, it's not too late — especially as "we are entering a phase when COVID-19 cases are increasing," Marks said.
The updated vaccines from Moderna and Pfizer are combination shots, containing half the original vaccine and half tweaked to match the BA.4 and BA.5 omicron strains that until recently were dominant. Now BA.5 descendants are responsible for most COVID-19 cases.
The CDC last month released the first real-world data showing that an updated booster, using either company's version, does offer added protection to adults. The analysis found the greatest benefit was in people who'd never had a prior booster, just two doses of the original COVID-19 vaccine — but that even those who'd had a summertime dose were more protected than if they'd skipped the newest shot.
veryGood! (29661)
Related
- Current, future North Carolina governor’s challenge of power
- Kenosha police arrested a Black man at Applebee’s. The actual suspects were in the bathroom
- John Anderson: The Wealth Architect's Journey from Wall Street to Global Dominance
- Suburban Detroit woman says she found a live frog in a spinach container
- Could your smelly farts help science?
- Last chance to pre-order new Samsung Galaxy devices—save up to $1,000 today
- Trump adviser Boris Epshteyn arrested in 2021 after groping complaints at club, police records show
- Tensions rise as West African nations prepare to send troops to restore democracy in Niger
- Meta releases AI model to enhance Metaverse experience
- Millions of kids are missing weeks of school as attendance tanks across the US
Ranking
- Louvre will undergo expansion and restoration project, Macron says
- Coal miners say new limits on rock dust could save some lives
- What is hip-hop? An attempt to define the cultural phenomenon as it celebrates 50 years
- Federal judge will hear arguments on potential takeover of New York City’s troubled jail system
- SFO's new sensory room helps neurodivergent travelers fight flying jitters
- Atlantic hurricane season is now predicted to be above-normal this year, NOAA says
- Supreme Court blocks, for now, OxyContin maker bankruptcy deal that would shield Sacklers
- Judge Chutkan to hear arguments in protective order fight in Trump’s 2020 election conspiracy case
Recommendation
Residents worried after ceiling cracks appear following reroofing works at Jalan Tenaga HDB blocks
Grocery deals, battery disposal and phone speed: These tech tips save you time and cash
'Transportation disaster' strands Kentucky students for hours, cancels school 2 days
Here's where inflation stands today — and why it's raising hope about the economy
The FTC says 'gamified' online job scams by WhatsApp and text on the rise. What to know.
Pilot, passenger avoid serious injury after small plane lands in desert south of Las Vegas
Review: Netflix's OxyContin drama 'Painkiller' is just painful
Man cited for animal neglect after dog dies in triple-digit heat during Phoenix hike